Our Team
Where decades of safety expertise meet your most complex challenges.
From initial safety strategies to ongoing surveillance, ClinRM provides the full spectrum of drug safety and pharmacovigilance support across the product lifecycle.
Board of Directors
Jeff Albers - MOMA Board Chair and Venture Partner, Atlas Ventures
Reid Huber, Ph.D. - Partner, Third Rock Ventures
Walt Kowtoniuk, Ph.D. - Venture Partner, Third Rock Ventures
Christoph Lengauer, Ph.D. - Co-Founder and CSO, Curie. Bio
Asit Parikh, M.D., Ph.D. - CEO, MOMA Therapeutics
Thilo Schroeder, Ph.D. - Partner, Nextech Invest
Amit Sinha - Managing Director, Goldman Sachs Asset Management
Susan Pandya, M.D. - VP, Clinical Development & Global Head of Late-stage Oncology, Servier Pharmaceuticals
Board Observers
Bihua Chen - CEO, Cormorant Asset Management
